New therapeutic strategies for juvenile idiopathic arthritis (JIA) have emerged over the past decade, prompting an update to the German management guidelines from 2011.
A systematic literature review and consensus conferences led to the development of 12 key therapeutic principles and specific recommendations for pharmacological (9) and non-pharmacological (5) treatments.
The updated guidelines emphasize evidence-based approaches and the importance of interdisciplinary collaboration to improve treatment for children and adolescents with JIA.